Polypill for cardiovascular disease prevention.

Polypill for cardiovascular disease prevention.

書誌詳細
第一著者:	Dalton, A
フォーマット:	Journal article
言語:	English
出版事項:	2013

類似資料

The Concept of the Polypill in the Prevention of Cardiovascular Disease
著者:: Brandon Wiley, 等
出版事項: (2014-04-01)

Polypills with or without aspirin for primary prevention of cardiovascular disease
著者:: Mant, J, 等
出版事項: (2021)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
著者:: Apichard Sukonthasarn, 等
出版事項: (2021-03-01)

Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease
著者:: J. Masjuan, 等
出版事項: (2021-01-01)

Medicinal herbs: Potential polypills in cardiovascular diseases
著者:: Samaneh Noroozi, 等
出版事項: (2021-04-01)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
著者:: Omneya A. Kandil, 等
出版事項: (2022-04-01)

The polypill: the solution for prevention of coronary heart disease?
著者:: Hendarto Natadidjaja
出版事項: (2016-02-01)

THE ROLE OF POLYTABLETS (POLYPILL) IN THE TREATMENT OF CHRONIC CARDIOVASCULAR DISEASES
著者:: Николай Владимирович Абрамов, 等
出版事項: (2024-02-01)

Polypill versus medication monotherapy in the prevention of cardiovascular diseases in Iran: An economic evaluation study
著者:: Ramin Ravangard, 等
出版事項: (2024-07-01)

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
著者:: Lilian Grigorian-Shamagian, 等
出版事項: (2021-08-01)

The use of polypills in cardiovascular disease management: Benefits vs challenges
著者:: Yamaan Adil, 等
出版事項: (2024-09-01)

Benefits of the Polypill on Medication Adherence in the Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review
著者:: Lopez-Lopez JP, 等
出版事項: (2023-09-01)

A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health Organization
著者:: Gunaratne Padma S, 等
出版事項: (2011-01-01)

A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
著者:: Gautam Satheesh, 等
出版事項: (2024-07-01)

Redefining the polypill: pros and cons in cardiovascular precision medicine
著者:: Siddharth Birla, 等
出版事項: (2023-09-01)

Exercise Rehabilitation in Heart Disease: the real “polypill” for primary and secondary prevention
著者:: Massimo F. Piepoli
出版事項: (2005-06-01)

Correction: A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
著者:: Gautam Satheesh, 等
出版事項: (2024-08-01)

Preventing the progression of climate change: one drug or polypill?
著者:: Hugh Montgomery
出版事項: (2017-03-01)

Polypill holds promise for people with chronic disease
著者:: Jacqui Wise
出版事項: (2005-12-01)

Polypill" conception in modern cardiology
著者:: I E Chazova, 等
出版事項: (2018-12-01)

Polypill revisited – Unity in diversity
著者:: Gheorghe-Andrei Dan, 等
出版事項: (2020-08-01)

Cost-Effectiveness of the CNIC-Polypill Strategy Compared With Separate Monocomponents in Secondary Prevention of Cardiovascular and Cerebrovascular Disease in Portugal: The MERCURY Study
著者:: Carlos Aguiar, 等
出版事項: (2022-11-01)

Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review.
著者:: Reza Jahangiri, 等
出版事項: (2022-01-01)

Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study
著者:: Cordero A, 等
出版事項: (2023-07-01)

Three-dimensional printing of flexible polypill
著者:: Yasir Karkar, 等
出版事項: (2023-12-01)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease
著者:: Jowett, S, 等
出版事項: (2017)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease.
著者:: Sue Jowett, 等
出版事項: (2017-01-01)

Polypill Brings Benefits to Patients with Cardiovascular Disease, Both Improving Medication Adherence and Demonstrating the Concept of Chronotherapy [Letter]
著者:: Zhu LL, 等
出版事項: (2023-09-01)

The Benefits of Polypill: Adherence and Chronotherapy [Response to Letter]
著者:: Lopez-Jaramillo P, 等
出版事項: (2023-10-01)

Has the polypill finally proven its worth?
著者:: Treadwell, J
出版事項: (2019)

Inclusion of Polypills for Prevention of Cardiovascular Disease in the 23rd World Health Organization Model List of Essential Medicines: A Significant Step Towards Reducing Global Cardiovascular Morbidity and Mortality
著者:: Anubha Agarwal, 等
出版事項: (2024-02-01)

The cardiovascular polypill as baseline treatment improves lipid profile and blood pressure regardless of body mass index in patients with cardiovascular disease. The Bacus study.
著者:: José Alejandro Chávez Fernández, 等
出版事項: (2023-01-01)

Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk
著者:: Usherwood Tim, 等
出版事項: (2010-08-01)

Would primary healthcare professionals prescribe a polypill to manage cardiovascular risk? A qualitative interview study
著者:: Virdee, S, 等
出版事項: (2013)

Effect of a Cardiovascular Polypill on Poststroke Cognition Among Ghanaians: Secondary Analysis of a Randomized Clinical Trial
著者:: Fred Stephen Sarfo, 等
出版事項: (2024-08-01)

Randomized Polypill crossover trial in people aged 50 and over.
著者:: David S Wald, 等
出版事項: (2012-01-01)

Polypill therapy and frailty in elderly: Time to stop treating everything
著者:: Sunil Kumar, 等
出版事項: (2021-04-01)

The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled trials.
著者:: C Raina Elley, 等
出版事項: (2012-01-01)

Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia
著者:: Hae Won Jung, 等
出版事項: (2023-09-01)

An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.
著者:: PILL Collaborative Group, 等
出版事項: (2011-01-01)